EWTX
Edgewise Therapeutics, Inc. · Healthcare
President and CEO Kevin Koch sold $29K of Edgewise Therapeutics, Inc.
Sold$28,522
$8.90Price
3,203Shares
−1%Stake
What EWTX did after the filing
- The stock from Wed, May 3 close, $9.25
- −5.7%
- S&P 500, same days
- +8.5%
Measured over 30 trading days, to the Jun 15 close.
Traded Tue, May 2. Filed Wed, May 3, 2:25 PM ET, during the session. Returns use the May 3 close and the Jun 15 close. Not investment advice.